OOIR: Observatory of International Research

Papers

(The H4-Index of Cardiovascular Research is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
The backstage of the Russian–Ukrainian war: refugees in urgent need of cardiovascular management	324
In vivo calcium and voltage mapping of the zebrafish heart	237
Novel ex-vivo calcification model for human aortic valves reveals patient-specific effect of compound	184
Clinical Case 08—A challenging clinical case: acute limb ischemia as a presentation of a left ventricular thrombus in a patient with heart failure with reduced ejection fraction	170
Timing of capillary enlargement after adenoviral VEGF gene transfer does not support post-ischemic skeletal muscle recovery in hyperlipidemic mice	162
FABP4 as potential indicator for GDM-induced fetal endothelial dysfunction	157
Oral Presentation No. 019 Bi-directional cross talk between coagulation, fibrinolysis and inflammatory pathways in patients with ST-segment elevation myocardial infarction	153
Impaired autophagy mechanisms associated with phospholamban-R14del disease	137
Poster No. 106 Can we optimize d-dimer cut off value to predict pulmonary embolism in covid-19 patients?	133
Clinical Case 18—Management of patient with cancer and confirmed systemic thrombosis and rectal bleeding	129
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity	129
Corrigendum to: CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression	128
Accelerating developments in heart failure	124
Elevated soluble ST2 and in-hospital mortality in patients with type A aortic dissection	119
Cardioprotection in cardio-oncology: a case for concern?	115
Rapamycin reduces atherosclerotic plaque inflammation in aged mice	112
Should we resurrect acetazolamide as a diuretic for congestion due to heart failure?	105
Early biomarkers of disease in hypertrophic cardiomyopathy: does telomere length matter?	100
Circulating dimethylguanidino valeric acid, dietary factors, and risk of coronary heart disease	100
Matrix metalloproteinase-3 joins a growing list of proteases that regulate vascular calcification	94
Cardioprotective MicroRNA (ProtectomiRs) identified in a porcine model of acute myocardial infarction and ischemic conditioning: in vitro validation of novel candidates	92
MiRNA-19b targets mineralocorticoid receptor and prevents calcification of female valve interstitial cells	91
EZH2 controls microRNA expression in T cells in atherosclerosis	89
Inhibition of dysregulated il-8-cxcr1 paracrine cellular crosstalk reverses cardiac hypertrophy and fibrosis in noonan syndrome	85
Low levels of endothelial nitric oxide synthase (eNOS) might serve as a potential indicator for recurrent atrial fibrillation	82

The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies	79
Defining HFpEF in rodents: a systematic review	76
Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence	76
Restraining fibrosis in cardiac repair	75
Targeting endothelial to mesenchymal transition in atherosclerosis	74
Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes	68
SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?	67
Aircraft noise exposure induces pro-inflammatory vascular conditioning and amplifies vascular dysfunction and impairment of cardiac function after myocardial infarction	67
Endothelial Rho kinase controls blood vessel integrity and angiogenesis	64
The mechanistic role of connexin 43 in maturation of hiPSC cardiomyocytes	64
ChemR23 signalling as a potential therapeutic target in atherosclerosis and cardiovascular diseases	63
TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells	62
PRDM16, a new kid on the block in cardiovascular health and disease	61
The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis	61
Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase	61
Corrigendum to: Transient stabilization of human cardiovascular progenitor cells from human pluripotent stem cells in vitro reflects stage-specific heart development in vivo	60
Keep your guard up: blood–brain barrier protection by empagliflozin after acute ischaemic stroke	59
MiR-92b-3p modulates apoptosis in smooth muscle cells through BCL2L11 regulation, unravelling novel therapeutic strategies for unstable plaques	59
Targeting serotonin receptor 7 to improve survival after myocardial infarction	58
Poster No. 142 An unusal heart-kidney connection: from diagnosis to staging of renal cell carcinoma	57
Poster No. 138 Thromboembolic and bleeding risks due to perioperative stop of antithrombotic treatment in non-cardiac surgery - a single center experience	55
Antisense oligonucleotides as a potential therapeutic strategy in hypertrophic cardiomyopathy caused by MYBPC3 variants	53
Generation of isogenic allelic series of LMNA-mutated hiPSC lines using the novel and highly-efficient targeting platform, STRAIGHT-IN	53
Untangling the inflammatory responses of liver x receptor (LXR) activation in human macrophages	53
High-throughput proteomic analysis unveils metabolic and mitochondrial signaling rewiring by chronic ivabradine treatment in duchenne muscular dystrophy	53
Poster No. 050 Klotho protein supports mechanical function and prevents MMP-mediated injury of heart during ischemia/reperfusion	51
Poster No. 098 SGLT2-inhibitors as add-on therapy in cardiac amyloidosis: our experience	51
Alterations in oxidative phosphorylation complexes in arrhythmogenic cardiomyopathy using desmosomal KO cell model	51